Seven Eight Capital’s GoHealth GOCO Stock Holding History

Seven Eight Capital’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,907	Closed	-$1.15M	–	496
2020 Q3	$1.15M	Buy	+5,907	New	+$1.42M	0.25%	131

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Seven Eight Capital's GOCO Position: Q4 2020 in Review

Seven Eight Capital sold out of GoHealth (GOCO) in Q4 2020, closing a stake of 5,907 shares — an estimated $1.15M sold.

Seven Eight Capital first reported a position in GOCO in Q3 2020 and held it in 1 quarter. The position peaked at $1.15M in Q3 2020. 99 funds tracked by Wall St. Rank hold GOCO as of Q4 2020.

Seven Eight Capital reported no remaining GoHealth position as of Q4 2020 after selling out during the quarter.
Seven Eight Capital sold 5,907 GoHealth shares in Q4 2020, an estimated $1.15M.
Seven Eight Capital first reported a position in GoHealth in Q3 2020 and held it in 1 quarter.
Seven Eight Capital's GoHealth position peaked at $1.15M in Q3 2020.
99 funds tracked by Wall St. Rank held GoHealth as of Q4 2020.

Based on Seven Eight Capital's 13F filing for Q4 2020, filed 9 Feb 2021.